Estimates Revisions Celltrion, Inc.

Stocks

End-of-day quote Korea S.E. Other stock markets 2026-07-10			5-day change	1st Jan Change
175,200.00 ^KRW	+1.21%		-4.58%	+1.64%

07-07	Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA	MT
07-03	South Korean Shares Jump on Bargain-Hunting, Chip Stock Gains	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	CELLTRION, INC.
	LONZA GROUP AG
	REVOLUTION MEDICINES, INC.
	IQVIA HOLDINGS INC.
	BEONE MEDICINES AG
	ASCENDIS PHARMA A/S			-
	MEDPACE HOLDINGS, INC.
	EUROFINS SCIENTIFIC SE
	ICON PUBLIC LIMITED COMPANY
	ABIVAX
	Average
	Weighted average by Cap.